Laureate Education Releases 2017 Global Impact Report and Honors Outstanding Students and Faculty
Oct 19, 2017 12:15 pm UTC| Business
BALTIMORE, Oct. 19, 2017 -- Laureate Education, Inc. (Nasdaq:LAUR), the global leader in higher education, released its 2017 Global Impact Report recognizing its impact across 25 countries, at nearly 70 institutions,...
Home BancShares, Inc. Announces Third Quarter Earnings
Oct 19, 2017 12:15 pm UTC| Business
CONWAY, Ark., Oct. 19, 2017 -- Home BancShares, Inc. (NASDAQ:HOMB), parent company of Centennial Bank, today announced a quarterly profit of $14.8 million for the third quarter of 2017 compared to $43.6 million, for the...
Truxton Corporation Reports Third Quarter 2017 Results
Oct 19, 2017 12:15 pm UTC| Business
NASHVILLE, Tenn., Oct. 19, 2017 -- Truxton Corporation (OTCPK:TRUX), a financial holding company and the parent of Truxton Trust Company (the “Bank”), reported consolidated net income of $1,604,000 for the third quarter...
American Premium Founder Alfred Culbreth Welcomes Gents, adds Revenue and Distribution
Oct 19, 2017 12:15 pm UTC| Business
PLAYA VISTA, Calif., Oct. 19, 2017 -- Furthering its mission to become a diversified consumer products company, American Premium Water Corporation (OTC:HIPH), producer of Lalpina Hydrogen Water, has signed a licensing...
Oct 19, 2017 12:05 pm UTC| Business
TUSTIN, Calif., Oct. 19, 2017 -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a company focused on helping improve patient lives by providing high quality biologics manufacturing services to...
Organovo Announces Release Date for Fiscal Second-Quarter 2018 Financial Results
Oct 19, 2017 12:05 pm UTC| Business
SAN DIEGO, Oct. 19, 2017 -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) will host a conference call on Thursday, November 9, 2017 at 5:00 p.m. Eastern Time (ET) to discuss the Company's fiscal second-quarter 2018...
Oct 19, 2017 12:02 pm UTC| Business
Lund, October 19, 2017 - Active Biotech (NASDAQ STOCKHOLM: ACTI) today announces that the collaboration partner Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) will present new data on laquinimod, an...